Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RGLS Regulus Therapeutics Inc

已收盘 05-01 16:00:00 EDT

2.51

+0.21

+9.13%

盘后2.51

+0.000.00%

19:43 EDT

最高2.67	最低2.21	成交量56.29万
今开2.30	昨收2.30	日振幅20.00%
总市值1.64亿	流通市值1.04亿	总股本6,547万
成交额137.19万	换手率1.35%	流通股本4,155万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RGLS","market":"US","secType":"STK","nameCN":"Regulus Therapeutics Inc","latestPrice":2.51,"timestamp":1714593600000,"preClose":2.3,"halted":0,"volume":562862,"hourTrading":{"tag":"盘后","latestPrice":2.51,"preClose":2.51,"latestTime":"19:43 EDT","volume":36,"amount":88.96,"timestamp":1714607038454},"delay":0,"floatShares":41551318,"shares":65465251,"eps":-1.584196,"marketStatus":"已收盘","marketStatusCode":5,"change":0.21,"latestTime":"05-01 16:00:00 EDT","open":2.3,"high":2.67,"low":2.21,"amount":1371939.5389699999,"amplitude":0.2,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.584196,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714636800000},"adr":0,"listingDate":1349323200000,"adjPreClose":2.3,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":2.51,"preClose":2.51,"latestTime":"19:43 EDT","volume":36,"amount":88.96,"timestamp":1714607038454},"volumeRatio":3.336914},"requestUrl":"/m/hq/s/RGLS/wiki","defaultTab":"wiki","newsList":[{"id":"2432068050","title":"Regulus Therapeutics Inc.盘中异动 股价大涨5.65%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432068050","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432068050?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:26","pubTimestamp":1714587976,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时26分，Regulus Therapeutics Inc.股票出现波动，股价大幅拉升5.65%。截至发稿，该股报2.43美元/股，成交量25.624万股，换手率0.39%，振幅8.70%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502022616861ea912&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502022616861ea912&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429116006","title":"Regulus Therapeutics Inc.盘中异动 快速拉升5.45%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429116006","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429116006?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:59","pubTimestamp":1713884378,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时59分，Regulus Therapeutics Inc.股票出现波动，股价大幅上涨5.45%。截至发稿，该股报2.32美元/股，成交量4.9821万股，换手率0.08%，振幅7.27%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.65%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423225939861e835e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423225939861e835e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428669595","title":"Regulus Therapeutics Inc.盘中异动 急速下跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428669595","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428669595?lang=zh_cn&edition=full","pubTime":"2024-04-20 00:12","pubTimestamp":1713543136,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日00时12分，Regulus Therapeutics Inc.股票出现波动，股价大幅跳水5.41%。截至发稿，该股报2.10美元/股，成交量10.3765万股，换手率0.16%，振幅8.11%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200012167921e9dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200012167921e9dd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428208543","title":"Regulus Therapeutics Inc.盘中异动 下午盘股价大跌5.13%报2.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428208543","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428208543?lang=zh_cn&edition=full","pubTime":"2024-04-19 02:20","pubTimestamp":1713464441,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日02时20分，Regulus Therapeutics Inc.股票出现波动，股价急速跳水5.13%。截至发稿，该股报2.22美元/股，成交量11.9056万股，换手率0.18%，振幅6.20%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419022042861e7212&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419022042861e7212&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428455483","title":"Regulus Therapeutics Inc.盘中异动 股价大跌5.47%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428455483","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428455483?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:30","pubTimestamp":1713360623,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时30分，Regulus Therapeutics Inc.股票出现波动，股价急速下跌5.47%。截至发稿，该股报2.42美元/股，成交量3579股，换手率0.01%，振幅0.00%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Vanda Pharmaceuticals Inc.、Clene Inc.、Purple Biotech Ltd涨幅较大，Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃，换手率分别为24.04%、21.24%、14.99%，振幅较大的相关个股有Coya Therapeutics, Inc.、180 Life Sciences Corp.、Vanda Pharmaceuticals Inc.，振幅分别为5.51%、4.73%、4.44%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041721302387e815cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041721302387e815cb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427587335","title":"Regulus Therapeutics Inc.盘中异动 早盘快速下挫5.40%报2.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427587335","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427587335?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:53","pubTimestamp":1713275601,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时53分，Regulus Therapeutics Inc.股票出现波动，股价急速跳水5.40%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.84%。其相关个股中，Palisade Bio, Inc.、Jaguar Health, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Palisade Bio, Inc.、Biorestorative Therapies, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为1820.01%、106.30%、52.85%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Palisade Bio, Inc.、Jaguar Health, Inc.，振幅分别为101.94%、65.38%、49.83%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162153217a532e5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162153217a532e5d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427200020","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427200020","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427200020?lang=zh_cn&edition=full","pubTime":"2024-04-15 23:23","pubTimestamp":1713194631,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日23时23分，Regulus Therapeutics Inc.股票出现波动，股价快速下跌5.00%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，安皮奥制药、Soligenix, Inc.、Longeveron Inc.涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1384.03%、1108.23%、796.19%，振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为273.33%、90.70%、80.04%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症，代谢性疾病，纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415232352861e5da4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415232352861e5da4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426402261","title":"Regulus Therapeutics Inc.盘中异动 急速上涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426402261","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426402261?lang=zh_cn&edition=full","pubTime":"2024-04-11 23:21","pubTimestamp":1712848861,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日23时21分，Regulus Therapeutics Inc.股票出现异动，股价大幅上涨5.34%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.82%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Adial Pharmaceuticals, Inc、Scisparc Ltd.、Aptevo Therapeutics Inc.较为活跃，换手率分别为652.69%、485.34%、468.59%，振幅较大的相关个股有Rallybio Corporation、Tc Biopharm  Plc C/Wts 10/02/2028 、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为50.92%、46.31%、40.90%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症，代谢性疾病，纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112321017a522fd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112321017a522fd4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426494497","title":"Regulus Therapeutics Inc.盘中异动 股价大跌5.19%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426494497","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426494497?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:38","pubTimestamp":1712756327,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时38分，Regulus Therapeutics Inc.股票出现异动，股价急速下跌5.19%。截至发稿，该股报2.56美元/股，成交量1.0216万股，换手率0.02%，振幅2.96%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.38%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症，代谢性疾病，纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021384787e7f4ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021384787e7f4ba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424453390","title":"Regulus Therapeutics Inc.盘中异动 快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424453390","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424453390?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:40","pubTimestamp":1712065246,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时40分，Regulus Therapeutics Inc.股票出现波动，股价急速下跌5.00%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.39%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Avalo Therapeutics, Inc.、Imunon, Inc.较为活跃，换手率分别为556.55%、15.25%、10.98%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Aditxt, Inc.、Orgenesis Inc.，振幅分别为48.62%、44.65%、25.80%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症，代谢性疾病，纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040221404787e7da0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040221404787e7da0e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422649081","title":"Regulus Therapeutics Inc.盘中异动 大幅拉升5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422649081","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422649081?lang=zh_cn&edition=full","pubTime":"2024-03-27 00:46","pubTimestamp":1711471579,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日00时46分，Regulus Therapeutics Inc.股票出现波动，股价快速拉升5.32%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Nutriband Inc C/Wts 、Artelo Biosciences Inc C/Wts 20/06/2024 、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Abvc Biopharma, Inc.、Mesoblast Ltd、Altamira Therapeutics Ltd.较为活跃，换手率分别为234.42%、50.21%、40.95%，振幅较大的相关个股有Nutriband Inc C/Wts 、Artelo Biosciences Inc C/Wts 20/06/2024 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为145.76%、109.21%、97.22%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403270046207a4f39ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403270046207a4f39ea&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422510520","title":"Regulus Therapeutics Inc.盘中异动 快速拉升6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422510520","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422510520?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:37","pubTimestamp":1711373842,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时37分，Regulus Therapeutics Inc.股票出现波动，股价快速上涨6.13%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1273.60%、49.24%、31.39%，振幅较大的相关个股有Altamira Therapeutics Ltd.、Xtl生物制药、Matinas Biopharma Holdings, Inc.，振幅分别为27.17%、19.84%、13.96%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252137227a4ee82a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252137227a4ee82a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421043241","title":"Regulus Therapeutics Inc.盘中异动 早盘急速上涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421043241","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421043241?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:35","pubTimestamp":1711028119,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时35分，Regulus Therapeutics Inc.股票出现异动，股价大幅拉升5.20%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症，代谢性疾病，纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212135207a4e4099&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212135207a4e4099&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420227119","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.30%报2.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420227119","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420227119?lang=zh_cn&edition=full","pubTime":"2024-03-19 21:39","pubTimestamp":1710855557,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日21时39分，Regulus Therapeutics Inc.股票出现波动，股价急速下挫5.30%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Fusion Pharmaceuticals Inc.、Enveric Biosciences, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为597.70%、167.52%、124.75%，振幅较大的相关个股有Enveric Biosciences, Inc.、Clearmind Medicine Inc.、Immuneering Corporation，振幅分别为32.73%、22.31%、17.58%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031921391887e7a105&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031921391887e7a105&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420255290","title":"美国研究综述-美国大厦、莱纳尔、耐克","url":"https://stock-news.laohu8.com/highlight/detail?id=2420255290","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420255290?lang=zh_cn&edition=full","pubTime":"2024-03-19 15:17","pubTimestamp":1710832652,"startTime":"0","endTime":"0","summary":"    路透社3月19日 - 华尔街证券分析师周二调整了对美国塔、莱纳尔和耐克等几家美国上市公司的评级和目标价。* 耐克公司   ：Wedbush将目标价从131美元下调至115美元 * Zoom Video Communications   ：杰富瑞给予该公司 \"持有 \"评级，目标价为70美元 以下是路透社周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419023607","title":"Regulus Therapeutics Inc.盘中异动 股价大跌8.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419023607","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419023607?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:51","pubTimestamp":1710424274,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时51分，Regulus Therapeutics Inc.股票出现波动，股价快速跳水8.25%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，知临集团、Revolution Medicines Inc C/Wts 17/12/2026 、Nutriband Inc C/Wts 涨幅较大，知临集团、Novabay Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为207.88%、135.03%、65.63%，振幅较大的相关个股有知临集团、180 Life Sciences Corp C/Wts 07/11/2025、Nuvectis Pharma, Inc.，振幅分别为66.97%、40.32%、38.38%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314215114861de3e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314215114861de3e1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419871680","title":"Regulus Therapeutics Inc.盘中异动 大幅拉升7.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419871680","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419871680?lang=zh_cn&edition=full","pubTime":"2024-03-13 21:54","pubTimestamp":1710338068,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日21时54分，Regulus Therapeutics Inc.股票出现异动，股价急速拉升7.99%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Nucana Plc、Kintara Therapeutics, Inc.涨幅较大，Kintara Therapeutics, Inc.、Nucana Plc、Revelation Biosciences, Inc.较为活跃，换手率分别为168.70%、54.03%、31.82%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Nucana Plc、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为82.54%、44.25%、32.67%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。MicroRNA治疗的目标是癌症，代谢性疾病，纤维化和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031321542987e78900&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031321542987e78900&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418537842","title":"Regulus Therapeutics Inc.股价上涨92.03% 市值涨4931.89万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418537842","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418537842?lang=zh_cn&edition=full","pubTime":"2024-03-12 21:31","pubTimestamp":1710250299,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日21时31分，Regulus Therapeutics Inc.股票出现波动，股价大幅拉升92.03%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Regulus Therapeutics Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Anaptysbio, Inc.涨幅较大，Regulus Therapeutics Inc.、Scisparc Ltd.、Tc Biopharm  Plc较为活跃，换手率分别为143.67%、126.52%、26.33%，振幅较大的相关个股有Regulus Therapeutics Inc.、Scorpius Holdings, Inc.、Aslan Pharmaceuticals Limited，振幅分别为34.35%、13.07%、12.26%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221313987773a28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221313987773a28&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418158471","title":"BUZZ-肾病疗法在早期试验中前景看好，Regulus 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2418158471","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2418158471?lang=zh_cn&edition=full","pubTime":"2024-03-12 18:50","pubTimestamp":1710240655,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月12日 - ** Regulus Therapeutics   股价盘前上涨65.2%至2.28美元** 该公司称，其治疗常染色体显性多囊肾病的疗法(ADPKD) 在一项早期试验中显示，根据尿液中多囊蛋白的水平，患者出现了反应** RGLS 称，多囊卵巢蛋白增幅最大的三名患者的肾囊肿总体积也有所减少** ADPKD 是多囊肾中最常见的一种，它会导致肾脏中长出许多囊肿，并可能导致肾衰竭。** 截至上次收盘，股价在过去 12 个月中上涨了 9.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regulusrx.com","stockEarnings":[{"period":"1week","weight":0.0177},{"period":"1month","weight":-0.2014},{"period":"3month","weight":0.811},{"period":"6month","weight":0.7037},{"period":"1year","weight":0.7692},{"period":"ytd","weight":0.7969}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":-0.0403},{"period":"3month","weight":0.0396},{"period":"6month","weight":0.1653},{"period":"1year","weight":0.2081},{"period":"ytd","weight":0.0561}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Regulus Therapeutics Inc.成立于2007年9月6日。该公司是一家临床阶段的生物制药公司，致力于发现和开发针对microRNA的一流药物，以治疗具有重大医疗需求的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":-0.016722},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.00374},{"month":3,"riseRate":0.5,"avgChangeRate":0.090028},{"month":4,"riseRate":0.25,"avgChangeRate":-0.057759},{"month":5,"riseRate":0.636364,"avgChangeRate":0.092462},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.110139},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.143516},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.040039},{"month":9,"riseRate":0.363636,"avgChangeRate":0.00074},{"month":10,"riseRate":0.181818,"avgChangeRate":0.034742},{"month":11,"riseRate":0.416667,"avgChangeRate":0.053637},{"month":12,"riseRate":0.416667,"avgChangeRate":0.0557}],"exchange":"NASDAQ","name":"Regulus Therapeutics Inc","nameEN":"Regulus Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Regulus Therapeutics Inc(RGLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Regulus Therapeutics Inc,RGLS,Regulus Therapeutics Inc股票,Regulus Therapeutics Inc股票老虎,Regulus Therapeutics Inc股票老虎国际,Regulus Therapeutics Inc行情,Regulus Therapeutics Inc股票行情,Regulus Therapeutics Inc股价,Regulus Therapeutics Inc股市,Regulus Therapeutics Inc股票价格,Regulus Therapeutics Inc股票交易,Regulus Therapeutics Inc股票购买,Regulus Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Regulus Therapeutics Inc(RGLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}